104 related articles for article (PubMed ID: 413873)
1. Porcine Willebrand factor: a population of multimers.
Fass DN; Knutson GJ; Bowie EJ
J Lab Clin Med; 1978 Feb; 91(2):307-20. PubMed ID: 413873
[TBL] [Abstract][Full Text] [Related]
2. Purification of porcine and human ristocetin-Willebrand factor.
Olson JD; Brockway WJ; Fass DN; Bowie EJ; Mann KG
J Lab Clin Med; 1977 Jun; 89(6):1278-94. PubMed ID: 405441
[TBL] [Abstract][Full Text] [Related]
3. Disulfide bonds and the quaternary structure of factor VIII/von Willebrand factor.
Counts RB; Paskell SL; Elgee SK
J Clin Invest; 1978 Sep; 62(3):702-9. PubMed ID: 308512
[TBL] [Abstract][Full Text] [Related]
4. Von Willebrand activity of low molecular weight human Factor VIII increases by binding to gold granules.
Furlan M; Perret BA; Beck EA
Thromb Haemost; 1981 Jun; 45(3):242-6. PubMed ID: 6792738
[TBL] [Abstract][Full Text] [Related]
5. Studies on human antihemophilic factor. Evidence for a covalently linked subunit structure.
Switzer ME; McKee PA
J Clin Invest; 1976 Apr; 57(4):925-37. PubMed ID: 1084890
[TBL] [Abstract][Full Text] [Related]
6. Factor VIII/von Willebrand factor protein. Galactose a cryptic determinant of von Willebrand factor activity.
Gralnick HR
J Clin Invest; 1978 Aug; 62(2):496-9. PubMed ID: 307560
[TBL] [Abstract][Full Text] [Related]
7. Interactions of purified rat factor VIII/von Willebrand factor with rat and human platelets--effect of albumin and ristocetin.
Dejana E; Furlan M; Barbieri B; Donati MB; Beck EA
Thromb Haemost; 1984 Aug; 52(1):57-9. PubMed ID: 6437011
[TBL] [Abstract][Full Text] [Related]
8. Two distinct forms of Factor VIII coagulant protein in human plasma. Cleavage by thrombin, and differences in coagulant activity and association with von Willebrand factor.
Weinstein MJ; Chute LE
J Clin Invest; 1984 Feb; 73(2):307-16. PubMed ID: 6421875
[TBL] [Abstract][Full Text] [Related]
9. Heterogeneity of molecular size of factor VIII/von Willebrand factor in von Willbrand's disease.
Mikami S; Takahashi Y; Nishino M; Okubo Y; Fukui H
Thromb Haemost; 1981 Jun; 45(3):272-5. PubMed ID: 6792740
[TBL] [Abstract][Full Text] [Related]
10. Multimeric structure of factor VIII/von Willebrand factor in von Willebrand's disease.
Meyer D; Obert B; Pietu G; Lavergne JM; Zimmerman TS
J Lab Clin Med; 1980 Apr; 95(4):590-602. PubMed ID: 6965697
[TBL] [Abstract][Full Text] [Related]
11. von Willebrand factor: characterization of interaction among von Willebrand factor, ristocetin and platelet.
Hashimoto S; Suzuki K
Nihon Ketsueki Gakkai Zasshi; 1979 Dec; 42(6):851-63. PubMed ID: 317771
[No Abstract] [Full Text] [Related]
12. Comparative study on collagen-binding enzyme-linked immunosorbent assay and ristocetin cofactor activity assays for detection of functional activity of von Willebrand factor.
Turecek PL; Siekmann J; Schwarz HP
Semin Thromb Hemost; 2002 Apr; 28(2):149-60. PubMed ID: 11992238
[TBL] [Abstract][Full Text] [Related]
13. Studies of the human factor VIII/von Willebrand factor protein. III. Qualitative defects in von Willebrand's disease.
Gralnick HR; Coller BS; Sultan Y
J Clin Invest; 1975 Oct; 56(4):814-27. PubMed ID: 1080491
[TBL] [Abstract][Full Text] [Related]
14. Characterization of factor VIII related protein synthesized by human endothelial cell: a study of structure and function.
Chan V; Chan TK
Thromb Haemost; 1982 Oct; 48(2):177-81. PubMed ID: 6817445
[TBL] [Abstract][Full Text] [Related]
15. Direct radioimmune detection in human plasma of the association between factor VIII procoagulant protein and von Willebrand factor, and the interaction of von Willebrand factor-bound procoagulant VIII with platelets.
Moake JL; Weinstein MJ; Troll JH; Chute LE; Colannino NM
Blood; 1983 Jun; 61(6):1163-73. PubMed ID: 6404328
[TBL] [Abstract][Full Text] [Related]
16. Characterization of proteases in AHF concentrates: effect on factor VIII:von Willebrand protein as assessed by high-pressure gel permeation chromatography.
Orthner CL
J Lab Clin Med; 1984 Nov; 104(5):816-28. PubMed ID: 6436416
[TBL] [Abstract][Full Text] [Related]
17. Proceedings: Purification of ristocetin Willebrand factor (RWF).
Olson JD; Fass DN; Brockway WJ; Bowie EJ; Mann KG
Thromb Diath Haemorrh; 1975 Nov; 34(2):606. PubMed ID: 1081753
[No Abstract] [Full Text] [Related]
18. Electrophoretic heterogeneity of normal factor VIII/Von Willebrand protein, and abnormal electrophoretic mobility in patients with Von Willebrand's disease.
Sultan Y; Simeon J; Caen JP
J Lab Clin Med; 1976 Feb; 87(2):185-94. PubMed ID: 1082003
[TBL] [Abstract][Full Text] [Related]
19. The interaction of the factor VIII/von Willebrand factor complex with hematin.
Green D; Furby FH; Berndt MC
Thromb Haemost; 1986 Dec; 56(3):277-82. PubMed ID: 3105105
[TBL] [Abstract][Full Text] [Related]
20. Molecular biology of factor VIII/von Willebrand Factor.
Meyer D; McKee PA; Hoyer LW; Zimmerman TS; Gralnick HR
Thromb Haemost; 1978 Oct; 40(2):245-51. PubMed ID: 310584
[No Abstract] [Full Text] [Related]
[Next] [New Search]
